Implicit and explicit attitudes towards disease-modifying antirheumatic drugs as possible target for improving medication adherence

Objective This study aims to explore the contribution of implicit attitudes and associations towards conventional disease-modifying antirheumatic drugs (cDMARDs), alongside explicit measures, on medication-taking behaviour and clinical outcomes in adult patients with rheumatoid arthritis (RA). Methods In this observational study, implicit attitudes (positive-negative) and health-related associations (health-sickness) were measured with Single Category Implicit Association Tests, whereas explicit outcomes were measured with a bipolar evaluative adjective scale and the Beliefs about Medicines Questionnaire Specific. The primary outcome of this study was medication-taking behaviour subjectively measured by self-report (i.e. validated Compliance Questionnaire on Rheumatology) and objectively measured with electronic drug monitors over a 3 month period. Spearman rank correlations were used to describe correlations between implicit and explicit outcomes. Nested linear regression models were used to assess the additional value of implicit measures over explicit measures and patient-, clinical-, and treatment-related characteristics. Results Of the 1659 initially-invited patients, 254 patients with RA agreed to participate in this study. Implicit attitudes correlated significantly with necessity-concerns differential (NCD) scores (ρ = 0.13, P = 0.05) and disease activity scores (ρ = -0.17, P = 0.04), whereas implicit health-related associations correlated significantly with mean scores for explicitly reported health-related associations (ρ = 0.18, P = 0.004). Significant differences in age, number of DMARDs, biologic DMARD use, NCD-scores, and self-reported correct dosing were found between the four attitudinal profiles. Nested linear regression models revealed no additional value of implicit measures in explaining self-reported medication-taking behaviour and clinical outcomes, over and above all other variables. Conclusion Implicit attitudes and associations had no additional value in explaining medication-taking behaviour and clinical outcomes over and above often used explicitly measured characteristics, attitudes and outcomes in the studied population. Only age and NCD scores contributed significantly when the dependent variable was correct dosing measured with self-report.

[1]  I. Rosenstock.  Historical Origins of the Health Belief Model , 1974 .

[2]  Gerd Bohner,et al.  Attitudes and attitude change. , 2002, Annual review of psychology.

[3]  I. Ajzen,et al.  Prediction and change of health behavior: Applying the reasoned action approach. , 2007 .

[4]  A. Greenwald,et al.  Measuring individual differences in implicit cognition: the implicit association test. , 1998, Journal of personality and social psychology.

[5]  Andreu Català,et al.  Home detection of freezing of gait using support vector machines through a single waist-worn triaxial accelerometer , 2017, PloS one.

[6]  Brian A. Nosek.  CURRENT DIRECTIONS IN PSYCHOLOGICAL SCIENCE Implicit–Explicit Relations , 2022 .

[7]  Michael A. Olson,et al.  Implicit measures in social cognition. research: their meaning and use. , 2003, Annual review of psychology.

[8]  M. Karsdal,et al.  Is radiographic progression in radiographic axial spondyloarthritis related to matrix metalloproteinase degradation of extracellular matrix? , 2018, RMD Open.

[9]  P. Weiden,et al.  Implicit versus explicit attitudes toward psychiatric medication: Implications for insight and treatment adherence , 2009, Schizophrenia Research.

[10]  J. Bargh,et al.  Nonconscious processes and health. , 2013, Health psychology : official journal of the Division of Health Psychology, American Psychological Association.

[11]  angesichts der Corona-Pandemie,et al.  UPDATE , 1973, The Lancet.

[12]  M. Hiligsmann,et al.  A scoping review of studies comparing the medication event monitoring system (MEMS) with alternative methods for measuring medication adherence. , 2016, British journal of clinical pharmacology.

[13]  M. Suarez‐Almazor,et al.  Electronic monitoring of oral therapies in ethnically diverse and economically disadvantaged patients with rheumatoid arthritis: consequences of low adherence. , 2013, Arthritis and rheumatism.

[14]  James Jaccard,et al.  Journal of Personality and Social Psychology Predicting Ethnic and Racial Discrimination : A Meta-Analysis of IAT Criterion Studies , 2013 .

[15]  Jeffrey K Aronson,et al.  A new taxonomy for describing and defining adherence to medications. , 2012, British journal of clinical pharmacology.

[16]  S. van der Linden,et al.  The compliance-questionnaire-rheumatology compared with electronic medication event monitoring: a validation study. , 2003, The Journal of rheumatology.

[17]  M. Banaji,et al.  PREDICTIVE VALIDITY OF THE IAT 1 RUNNING HEAD : PREDICTIVE VALIDITY OF THE IAT Understanding and Using the Implicit Association Test : III . Meta-analysis of Predictive Validity , 2006 .

[18]  Jeanne M. Madden,et al.  Cost-related Medication Nonadherence in Older Patients with Rheumatoid Arthritis , 2013, The Journal of Rheumatology.

[19]  S. van der Linden,et al.  Development of a questionnaire to investigate patient compliance with antirheumatic drug therapy. , 1999, The Journal of rheumatology.

[20]  J. de Houwer,et al.  Implicit measures: A normative analysis and review. , 2009, Psychological bulletin.

[21]  L. Vismara,et al.  Parenting Stress, Mental Health, Dyadic Adjustment: A Structural Equation Model , 2017, Front. Psychol..

[22]  S. Pocock,et al.  The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. , 2008, Journal of clinical epidemiology.

[23]  S. Pocock,et al.  The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. , 2007, Preventive medicine.

[24]  S. Maes,et al.  Determinants of methotrexate adherence in rheumatoid arthritis patients , 2015, Clinical Rheumatology.

[25]  Malte Friese,et al.  Predicting voting behavior with implicit attitude measures: the 2002 German parliamentary election. , 2007, Experimental psychology.

[26]  B. Bender,et al.  Adherence intervention research: what have we learned and what do we do next? , 2003, The Journal of allergy and clinical immunology.

[27]  Elizabeth Salt,et al.  Adherence to Disease-Modifying Antirheumatic Drugs in Patients With Rheumatoid Arthritis: A Narrative Review of the Literature , 2010, Orthopedic nursing.

[28]  R. Timman,et al.  Does non-adherence to DMARDs influence hospital-related healthcare costs for early arthritis in the first year of treatment? , 2017, PloS one.

[29]  Anthony G. Greenwald,et al.  Predictive Validity of the Implicit Association Test in Studies of Brands, Consumer Attitudes, and Behavior , 2004 .

[30]  Timothy D. Wilson,et al.  A model of dual attitudes. , 2000, Psychological review.

[31]  S. van Dulmen,et al.  Perceived need to take medication is associated with medication non-adherence in patients with rheumatoid arthritis , 2014, Patient preference and adherence.

[32]  Klaus Lehnert,et al.  Cross-Comparison of Exome Analysis, Next-Generation Sequencing of Amplicons, and the iPLEX® ADME PGx Panel for Pharmacogenomic Profiling , 2016, Front. Pharmacol..

[33]  I. Ajzen.  Nature and operation of attitudes. , 2001, Annual review of psychology.

[34]  I. Ajzen.  The theory of planned behavior , 1991 .

[35]  Bertram Gawronski,et al.  What do implicit measures measure? , 2019, Wiley interdisciplinary reviews. Cognitive science.

[36]  Bertram Gawronski,et al.  A History of Implicit Social Cognition Where Is It Coming From? Where Is It Now? Where Is It Going? , 2010 .

[37]  Ross B. Steinman,et al.  The single category implicit association test as a measure of implicit social cognition. , 2006, Journal of personality and social psychology.

[38]  T. Saxne,et al.  Course of radiographic damage over 10 years in a cohort with early rheumatoid arthritis , 2003, Annals of the rheumatic diseases.

[39]  John Wong,et al.  EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs , 2010, Annals of the rheumatic diseases.

[40]  Brian A. Nosek,et al.  Understanding and using the implicit association test: I. An improved scoring algorithm. , 2003, Journal of personality and social psychology.

[41]  M. D. de Vera,et al.  What are the effects of medication adherence interventions in rheumatic diseases: a systematic review , 2015, Annals of the rheumatic diseases.

[42]  Julie Brunton,et al.  Implicit Processes, Self-Regulation, and Interventions for Behavior Change , 2017, Front. Psychol..

[43]  I. Wilson,et al.  ESPACOMP Medication Adherence Reporting Guideline (EMERGE) , 2018, Annals of Internal Medicine.

[44]  Implicit and explicit attitudes towards conventional and complementary and alternative medicine treatments: Introduction of an Implicit Association Test , 2016, Journal of health psychology.

[45]  L. Vandeberg,et al.  Disentangling Rheumatoid Arthritis Patients’ Implicit and Explicit Attitudes toward Methotrexate , 2016, Front. Pharmacol..

[46]  M. Dougados,et al.  Methods to improve medication adherence in patients with chronic inflammatory rheumatic diseases: a systematic literature review , 2018, RMD Open.

[47]  Claire-Lise Ackermann,et al.  Implicit attitudes and their measurement: Theoretical foundations and use in consumer behavior research , 2015 .

[48]  G. Kingsley,et al.  What are the consequences of early rheumatoid arthritis for the individual? , 2005, Best practice & research. Clinical rheumatology.

[49]  J. Urquhart,et al.  Identification and Assessment of Adherence-Enhancing Interventions in Studies Assessing Medication Adherence Through Electronically Compiled Drug Dosing Histories: A Systematic Literature Review and Meta-Analysis , 2013, Drugs.

[50]  M. Banaji,et al.  Implicit social cognition: attitudes, self-esteem, and stereotypes. , 1995, Psychological review.

[51]  L. Osterberg,et al.  Adherence to medication. , 2005, The New England journal of medicine.

[52]  J. Weinman,et al.  The beliefs about medicines questionnaire: The development and evaluation of a new method for assessing the cognitive representation of medication , 1999 .

[53]  J. Hilton,et al.  Attitudes and the Implicit Association Test. , 2001, Journal of personality and social psychology.

[54]  J. Busschbach,et al.  Nonadherence to disease modifying antirheumatic drugs in the first year after diagnosis: comparing three adherence measures in early arthritis patients. , 2016, Rheumatology.

[55]  J. Urquhart,et al.  Adherence to medications: insights arising from studies on the unreliable link between prescribed and actual drug dosing histories. , 2012, Annual review of pharmacology and toxicology.

[56]  M. Becker,et al.  Health Belief Model and Personal Health Behavior , 1976 .

[57]  Tsutomu Takeuchi,et al.  EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update , 2010, Annals of the rheumatic diseases.

[58]  Ellsworth Faris.  Attitudes and Behavior , 1928, American Journal of Sociology.

[59]  D. M. van der Heijde,et al.  How much does Disease Activity Score in 28 joints ESR and CRP calculations underestimate disease activity compared with the Simplified Disease Activity Index? , 2014, Annals of the rheumatic diseases.